Stock ZEAL ZEALAND PHARMA A/S
Add to a list
To use this feature you must be a member
Log inSign up

News Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen
Other stock markets
 11:20:00 2024-11-29 EST 		5-day change 1st Jan Change
730.00 DKK -.--% Intraday chart for Zealand Pharma A/S +0.48% +95.61%
11-21 Zealand Pharma A/S Presents at Jefferies London Healthcare Conference 2024, Nov-21-2024 09:30 AM
11-20 KBC Securities Initiates Zealand Pharma at Buy MT

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Zealand Pharma A/S Presents at Jefferies London Healthcare Conference 2024, Nov-21-2024 09:30 AM
11-21
KBC Securities Initiates Zealand Pharma at Buy
11-20
 MT
Zealand Pharma to participate in the Jefferies London Healthcare Conference
11-13
 GL
Zealand Pharma to participate in the Jefferies London Healthcare Conference
11-13
 AQ
Zealand Pharma A/S - Transactions in Zealand Pharma shares and or related securities by persons discharging managerial responsibilities and or their closely associated persons
11-12
 AQ
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
11-11
 GL
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
11-11
 AQ
Zealand Pharma A/S : Presentation slides (zealand pharma q3 2024 presentation 7 november)
11-08
 PU
Zealand Pharma rallies after JP Morgan initiates Overweight rating
11-08
 FW
Zealand Pharma A/S : Interim Report for Q3 2024
11-08
 PU
Danske Bank raises Zealand Pharma to 'Keep' (Sell), target price 825 Danish kroner - BN
11-08
 FW
Goldman Sachs lowers target price for Zealand Pharma to DKK 1,095 (1,106), reiterates Buy - BN
11-08
 FW
JP Morgan initiates coverage of Zealand Pharma with Overweight and target price of DKK 1,100 - BN
11-08
 FW
Zealand Pharma A/S, Q3 2024 Earnings Call, Nov 07, 2024
11-07
Zealand Pharma Announces Financial Results for the First Nine Months of 2024
11-07
 GL
Zealand Pharma Announces Financial Results for the First Nine Months of 2024
11-07
 AQ
Zealand Pharma A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
11-07
 CI
Zealand Pharma reports promising results for weight loss drug - BN
11-06
 FW
Zealand Pharma conference call on November 7 at 2pm CET to Present third quarter 2024 financial results
11-04
 AQ
Novo Nordisk share price falls after Viking Therapeutics pill update
11-04
 FW
Zealand Pharma conference call on November 7 at 2pm CET (8am ET) to present third quarter 2024 financial results
11-01
 GL
Zealand Pharma conference call on November 7 at 2pm CET (8am ET) to present third quarter 2024 financial results
11-01
 AQ
Today's stock recommendations at a glance
10-15
 FW
Bank of America initiates coverage of Zealand Pharma with Buy and target price of DKK 1,100 - BN
10-15
 FW
Zealand Pharma falls after getting CRL from FDA
10-09
 FW
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZEAL Stock
  4. News Zealand Pharma A/S
LAST HOURS | BLACK FRIDAY -40%: Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition